Increlex® (mecasermin) 

Our video library provides helpful information about Increlex®. You can explore videos including a first-hand account of treatment from Olive, a former Increlex patient, and her mom, Renee; how Increlex works; and dosing information.

Increlex is a treatment for children age 2+ years with severe primary IGF-1 deficiency (SPIGFD) or growth hormone (GH) gene deletion who have developed neutralizing antibodies to GH. For additional information, please visit Increlex.com. Please see Full Prescribing Information link below.

Please see the full Important Safety Information on our page.

INCRELEX® is a registered trademark of Eton Pharmaceuticals, Inc.  
©2025 Eton Pharmaceuticals, Inc. All right reserved. 2053-v1